Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01723462
Other study ID # SLB-ED-02-2012
Secondary ID
Status Completed
Phase N/A
First received November 5, 2012
Last updated November 7, 2012
Start date August 2008
Est. completion date March 2009

Study information

Verified date November 2012
Source University of Southern Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: The Regional Committee on Biomedical Research Ethics
Study type Observational

Clinical Trial Summary

Clinical pharmacy has played a role in Emergency Departments (ED). The presence of pharmacists have been shown to reduce medication errors and improve the medication history taken at admission. In Denmark a recent study revealed that clinical pharmacists identified medication problems in 25% of all admission to the ED, of which 47 % were considered to be serious.

However, the pharmacist recommendations are of little value if they are not acknowledged or followed by the physicians.

The aim of the present study was to analyze how often and under which circumstances the physicians made use of pharmaceutical recommendations in an ED with a mixed patient population with special attention to those recommendations, which were of significant or disastrous importance.


Recruitment information / eligibility

Status Completed
Enrollment 301
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender Both
Age group 15 Years and older
Eligibility Inclusion Criteria:

- all acute admissions to emergency department who were treated with one or more drugs

Exclusion Criteria:

- children less than 15 years.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Denmark Kolding Sygehus Kolding

Sponsors (1)

Lead Sponsor Collaborator
University of Southern Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of pharmacist recommendations up to 48 hours after admission No